Trade Mark Journal No.2026/028 10 July 2026
WO0000001924018 (5,9,10,41,42)
Office of origin: Switzerland
Date of International Registration:8 April 2026
Date of designation in the UK:
8 April 2026
The mark contains the colours orange, blue and black
International priority date claimed: 5 March 2026
(Switzerland)
- Class 5
- Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the peripheral nervous system; pharmaceutical preparations used in organ transplantation; pharmaceutical preparations for the central nervous system; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of eye diseases and conditions; radioactive pharmaceutical preparations for use in vivo for diagnostic or therapeutic use.
- Class 9
- Downloadable computer software for controlling and managing patient medical information.
- Class 10
- Medical apparatus for introducing pharmaceutical preparations into the human body.
- Class 41
- Providing online non-downloadable publications in the nature of training materials in the field of health and medical information.
- Class 42
- Pharmaceutical research and development services.
Novartis AG
Representative: Keller Schneider Patent- und Markenanwälte AG, Beethovenstrasse 49,, Postfach, CH-8027 Zürich, SWITZERLAND